Rooney CM - Search Results

1

Foster AE, Rooney CM. Foster AE, et al. Among authors: rooney cm. Expert Opin Biol Ther. 2006 Mar;6(3):215-29. doi: 10.1517/14712598.6.3.215. Expert Opin Biol Ther. 2006. PMID: 16503732 Review.

2

Gene and cell transfer for specific immunotherapy.

Brenner MK, Heslop HE, Rooney CM. Brenner MK, et al. Among authors: rooney cm. Vox Sang. 1998;74 Suppl 2:87-90. doi: 10.1111/j.1423-0410.1998.tb05401.x. Vox Sang. 1998. PMID: 9704428 Review.

3

EBV specific CTL: a model for immune therapy.

Rooney CM, Heslop HE, Brenner MK. Rooney CM, et al. Vox Sang. 1998;74 Suppl 2:497-8. doi: 10.1111/j.1423-0410.1998.tb05463.x. Vox Sang. 1998. PMID: 9704488 Review.

4

Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation.

Aguilar LK, Rooney CM, Heslop HE. Aguilar LK, et al. Among authors: rooney cm. Curr Opin Oncol. 1999 Mar;11(2):96-101. doi: 10.1097/00001622-199903000-00004. Curr Opin Oncol. 1999. PMID: 10188073 Review.

5

Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant.

Heslop HE, Perez M, Benaim E, Rochester R, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. J Clin Apher. 1999;14(3):154-6. doi: 10.1002/(sici)1098-1101(1999)14:3<154::aid-jca9>3.0.co;2-k. J Clin Apher. 1999. PMID: 10540372 Review.

6

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation.

Kuehnle I, Huls MH, Liu Z, Semmelmann M, Krance RA, Brenner MK, Rooney CM, Heslop HE. Kuehnle I, et al. Among authors: rooney cm. Blood. 2000 Feb 15;95(4):1502-5. Blood. 2000. PMID: 10666232 Free article.

7

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Heslop H, et al. Hum Gene Ther. 2000 Jul 1;11(10):1465-75. doi: 10.1089/10430340050057530. Hum Gene Ther. 2000. PMID: 10910143 Clinical Trial. No abstract available.

8

Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.

You Z, Huang XF, Hester J, Rollins L, Rooney C, Chen SY. You Z, et al. J Immunol. 2000 Oct 15;165(8):4581-91. doi: 10.4049/jimmunol.165.8.4581. J Immunol. 2000. PMID: 11035100

9

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.

Gottschalk S, Ng CY, Perez M, Smith CA, Sample C, Brenner MK, Heslop HE, Rooney CM. Gottschalk S, et al. Among authors: rooney cm. Blood. 2001 Feb 15;97(4):835-43. doi: 10.1182/blood.v97.4.835. Blood. 2001. PMID: 11159505 Free article.

10

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients.

Savoldo B, Heslop HE, Rooney CM. Savoldo B, et al. Among authors: rooney cm. Leuk Lymphoma. 2000 Nov;39(5-6):455-64. doi: 10.3109/10428190009113376. Leuk Lymphoma. 2000. PMID: 11342329 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters